ANGEL GUTIERREZ: Open Payments
NPI 1538889357 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 78 payments from 16 companies in 2025. Trend: 2023 $19 · 2024 $544 · 2025 $1,762
Food & beverage: $1,744Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $542 |
| GlaxoSmithKline, LLC. | 14 | $279 |
| ABBVIE INC. | 5 | $160 |
| Viatris Specialty LLC | 8 | $153 |
| Regeneron Healthcare Solutions, Inc. | 6 | $125 |
| Insmed, Inc. | 4 | $87 |
| Actelion Pharmaceuticals US, Inc. | 4 | $84 |
| Grifols USA, LLC | 3 | $59 |
| Vifor Pharma, Inc. | 3 | $59 |
| Amgen Inc. | 3 | $58 |
Products named: TEZSPIRE, DUPIXENT, NUCALA, YUPELRI, FASENRA, TRELEGY ELLIPTA, BOTOX, Arikayce.
Industry payments across NM — which companies pay providers there.
